IP Verse

Iron Complex Compounds For Therapeutic Use

Patent No. EP3681539 (titled "Iron Complex Compounds For Therapeutic Use") was filed by Pharmacosmos Holding on Sep 10, 2018. The application was issued on Jan 1, 2025.

Patent Summary

Iron complex compounds with low levels of impurities like arsenic, chromium, lead, mercury, cadmium, and aluminum for safe administration to humans and animals. The compounds are iron carbohydrate complexes like hydrogenated oligoisomaltose. They are made by a process involving extracting iron from an aqueous solution with an organic solvent. This removes impurities. The resulting iron complex is purer and safer than conventional iron preparations.

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BARDEHLE PAGENBERGOct 1, 2025BARDEHLE PAGENBERG SL
BRIGHTGENE BIO MEDICAL TECHNOLOGYOct 1, 2025PLASSERAUD
SANDOZOct 1, 2025ELKINGTON AND FIFE
INTERQUIMSep 30, 2025FERRER INTERNACIONAL
SCORPIOSep 30, 2025SAGITTARIUS
ZIMMERMANN & PARTNER PATENTANWALTE MBBSep 30, 2025ZIMMERMANN & PARTNER PATENTANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3681539

PHARMACOSMOS HOLDING
Application Number
EP18762868A
Filing Date
Sep 10, 2018
Status
Granted And Under Opposition
Nov 29, 2024
Publication Date
Jan 1, 2025
External Links
Slate, Register , Google Patents